Dr. Fang is an internationally recognized expert in the field of transcatheter valve therapies (TAVR-Transcatheter Aortic Valve Replacement), and has a special interest in minimally invasive heart and lung surgeries.
He has been voted “Top Doctor” in the field of Cardiothoracic Surgery by his physician peers as featured in Phoenix Magazine for 12 consecutive years. Dr. Fang is regarded as a national expert in the surgical treatment of Atrial Fibrillation. He is also credited as one of the first surgeons to perform a DaVinci robotic assisted heart surgery in the state of Arizona.
A board-certified cardiothoracic surgeon, he has practiced in Phoenix for nearly two decades. Dr. Fang is a Clinical Associate Professor of Surgery at the University of Arizona College of Medicine in Phoenix and Chief of Cardiothoracic Surgery at the Banner University Medical Center in Phoenix.
Dr. Fang earned his medical degree from the University of Illinois College of Medicine in Chicago. He completed his general surgery residency at the Cook County Hospital in Chicago, where he was selected as the chief administrative resident. He then completed his cardiothoracic surgery fellowship training at Northwestern University in Chicago. He has board certifications by the American Board of Thoracic Surgery, The American Board of Surgery and the National Board of Medical Examiners.
HONORS & AWARDS
- Voted “Top Doctors” in Cardiovascular and Thoracic Surgery, Phoenix Magazine.
- Selected by Physicians in the Phoenix Metropolitan Area.
- 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017.
CERTIFICATION & LICENSURE
- Arizona Medical Board
- American Board of Thoracic Surgery
- American Board of Surgery
- National Board of Medical Examiners
PROFESSIONAL ORGANIZATIONS
- American Medical Association
- American College of Surgeons - Fellow
- Society of Thoracic Surgeons
PUBLICATIONS AND RESEARCH EXPERIENCE
A US Multicenter Registry For Percutaneous Transcatheter Mitral Valve Replacement Using Balloon Expandable Valve in Patients Who are at Prohibitive Risk for Surgery. D Verma, et al, K Fang. Accepted for TCT 2017.
D Verma, et al, K Fang. Derivation of TAVR Combined Moratality and Morbidity Risk Score for Predicting 1 Year Mortality and Morbidity After TAVR. Accepted for TCT 2017.
D Verma, et al, K Fang. Percutaneous Transcatheter Mitral Valve Replacement via Transseptal or Tansapical Approach in Patients Who Are Prohibitive Risk for Surgery: US Multicenter Registry. Accepted for TCT 2017.
Guerra, M, D Wang, S Vemulapalli, K Xiang, M Salinger, M Eleid, A Greenbaum, S Kodali, I George, B Whisenant, S Pershad, K Fang, M Coylewright, PB Shah, V Thourani, V Babaliaros, C Tommaso, J Saucedo, S Kar, R Macker, M Leon, C Rizal, W O’Neill, T Feldman. Clinical Outcomes of Transcatheter Mitral Valve Replacement for Degenerative Mitral Bioprosthesis (Mitral Valve in Valve) and Surgical Rings (Mitral Valve in Ring) in the United States: Data from the STS/ACC/TVT Registry. Accepted by AHA 2017. 21653
Guerra, M, D Wang, A Pursnani, M Salinger, H Russell, A Greenbaum, T Chakravarty, M Eleid, C Meduri, V Rajagopal, S Kodali, I George , L Stadler, G Aldea, A Pershad, K Fang, R Waksman, J Saucedo, M Reisman, C Rihal, S Kar, R Makkar, M Leon, T Feldman, W O’Neill. 30-Day Outcomes of Transseptal Transcatheter Mitral Valve Replacement for Failed Surgical Rings (Mitral Valve-in-Ring): The MITRAL Trial (Mitral Implantation of TRAnscatheter vaLves) Accepted by TCT 2017.
Verma, D, K Fang. Impact of Patent Foramen Ovale and Intracardiac Devices on Traditional Risk Factors for Stroke: When Low Risk Means High Risk? Accepted for AHA 2017.
Verma, D, K Fang. CHA2DS2-VASc Score Predicts Incidence-Rate of Stroke in Patients with Known Patent Foramen Ovale: A Long-term (10 year) Follow Up Study. Submitted to AHA 2017.
PRESENTATIONS
6th Annual Northern Arizona Cardio Conference for Primary Care. “Structural Valve Therapies: TMVR, The Next Frontier” October 6-7, 2017. Flagstaff, AZ
2nd Annual Banner Cardiology Summit. Contemporary Management of Structural Heart Disease in 2017. “Structural Valve Therapies: TMVR, The Next Frontier” September 20, 2017. Phoenix, AZ
Faculty for 2017 Edwards Lifescience Sapien 3 Valve-in-Valve Transcatheter Mitral Vale Replacement Physician Training Program September 14-15, 2017. Chicago, IL
Faculty for 2017 Edwards Lifescience Sapien 3 Valve-in-Valve Transcatheter Mitral Vale Replacement Proctor Training Program May 4-5, 2017. Chicago, IL
Faculty for 2017 Edwards Lifescience Fundamentals TAVR Training Program for graduating Cardiology and Cardiothoracic Surgery Fellows. February 8-10, 2017. Scottsdale, AZ
64th Annual Japanese Association for Thoracic Surgery. “TAVR and the Hybrid Operating Room” October 2, 2014. Fukuoka, Japan.
Scottsdale Interventional forum 2014. “Live Satellite Broadcast: Sapien Trans-Apical TAVR Procedure” February 25, 2014. Phoenix, AZ
